These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10023432)

  • 1. New amide local anaesthetics for obstetric use.
    Yun EM; Meadows W; Santos AC
    Baillieres Clin Obstet Gynaecol; 1998 Sep; 12(3):461-71. PubMed ID: 10023432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ropivacaine.
    Owen MD; Dean LS
    Expert Opin Pharmacother; 2000 Jan; 1(2):325-36. PubMed ID: 11249552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions.
    Thomas JM; Schug SA
    Clin Pharmacokinet; 1999 Jan; 36(1):67-83. PubMed ID: 9989343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levobupivacaine in obstetric analgesia and anaesthesia. Where is its place?].
    Bremerich DH; Zwissler B
    Anaesthesist; 2004 Jul; 53(7):637-44. PubMed ID: 15221118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local anaesthetics: what can the pure S enantiomers contribute?].
    Mazoit JX; Baujard C
    Ann Fr Anesth Reanim; 2006 Apr; 25(4):408-12. PubMed ID: 16455227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on ropivacaine.
    Wang RD; Dangler LA; Greengrass RA
    Expert Opin Pharmacother; 2001 Dec; 2(12):2051-63. PubMed ID: 11825334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidural ropivacaine 7.5 mg/ml for elective Caesarean section: a double-blind comparison of efficacy and tolerability with bupivacaine 5 mg/ml.
    Bjørnestad E; Smedvig JP; Bjerkreim T; Narverud G; Kollerøs D; Bergheim R
    Acta Anaesthesiol Scand; 1999 Jul; 43(6):603-8. PubMed ID: 10408812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane effects of ropivacaine compared with those of bupivacaine and mepivacaine.
    Mizogami M; Tsuchiya H; Harada J
    Fundam Clin Pharmacol; 2002 Aug; 16(4):325-30. PubMed ID: 12570022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ropivacaine. A review of its pharmacology and therapeutic use in regional anaesthesia.
    Markham A; Faulds D
    Drugs; 1996 Sep; 52(3):429-49. PubMed ID: 8875132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do "lefthanders" make better local anesthetics? The relevance of stereoisomerism in clinical practice as shown by new local anesthetics].
    Wulf H
    Anaesthesist; 1997 Jul; 46(7):622-6. PubMed ID: 9304365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative local anesthetic efficacy and pharmacokinetics of epidurally administered ropivacaine and bupivacaine in the sheep.
    Feldman HS; Dvoskin S; Halldin MH; Ask AL; Doucette AM
    Reg Anesth; 1997; 22(5):451-60. PubMed ID: 9338908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The toxicity of local anesthetics: the place of ropivacaine and levobupivacaine.
    Zink W; Graf BM
    Curr Opin Anaesthesiol; 2008 Oct; 21(5):645-50. PubMed ID: 18784493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary effects of bupivacaine, ropivacaine, and levobupivacaine in parturients undergoing spinal anaesthesia for elective caesarean delivery: a randomised controlled study.
    Lirk P; Kleber N; Mitterschiffthaler G; Keller C; Benzer A; Putz G
    Int J Obstet Anesth; 2010 Jul; 19(3):287-92. PubMed ID: 20605441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimum local anaesthetic dose (MLAD) of intrathecal levobupivacaine and ropivacaine for Caesarean section.
    Parpaglioni R; Frigo MG; Lemma A; Sebastiani M; Barbati G; Celleno D
    Anaesthesia; 2006 Feb; 61(2):110-5. PubMed ID: 16430561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in local anaesthetics for spinal anaesthesia.
    Milligan KR
    Eur J Anaesthesiol; 2004 Nov; 21(11):837-47. PubMed ID: 15717697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Density of spinal anaesthetic solutions of bupivacaine, levobupivacaine, and ropivacaine with and without dextrose.
    McLeod GA
    Br J Anaesth; 2004 Apr; 92(4):547-51. PubMed ID: 14766715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical safety with ropivacaine administration].
    Fornet Ruiz I; Palacio Abizanda FJ; Gilsanz F
    Rev Esp Anestesiol Reanim; 2002 Mar; 49(3):166. PubMed ID: 12136462
    [No Abstract]   [Full Text] [Related]  

  • 18. Benefit-risk assessment of ropivacaine in the management of postoperative pain.
    Zink W; Graf BM
    Drug Saf; 2004; 27(14):1093-114. PubMed ID: 15554745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropivacaine: a review of its use in regional anaesthesia and acute pain management.
    Simpson D; Curran MP; Oldfield V; Keating GM
    Drugs; 2005; 65(18):2675-717. PubMed ID: 16392884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sufentanil on minimum local analgesic concentrations of epidural bupivacaine, ropivacaine and levobupivacaine in nullipara in early labour.
    Buyse I; Stockman W; Columb M; Vandermeersch E; Van de Velde M
    Int J Obstet Anesth; 2007 Jan; 16(1):22-8. PubMed ID: 17125998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.